Hodgkin's Lymphoma Clinical Trials


Displaying all 3 Trial

A Study of Brentuximab Vedotin Combined With Nivolumab for Relapsed or Refractory Hodgkin Lymphoma

The purpose of this study is to assess the safety profile and antitumor activity of brentuximab vedotin administered in combination with nivolumab in patients with relapsed or refractory Hodgkin ly...

Diagnosis: Hodgkin's Lymphoma

Phase: 1 / 2

Protocol Number: 16-090

A Study of Nivolumab Plus Brentuximab Vedotin Versus Brentuximab Vedotin Alone in Patients With Advanced Stage Classical Hodgkin Lymphoma, Who Are Relapsed/ Refractory or Who Are Not Eligible for Autologous Stem Cell Transplant,

The purpose of this study is to determine whether an investigational immuno-therapy combination, nivolumab with Brentuximab vedotin compared to Brentuximab vedotin alone is safe and effective in th...

Diagnosis: Hodgkin's Lymphoma


Protocol Number: 17-282

Ivabradine in the Management of Cardiac Autonomic Dysfunction Associated With Thoracic Radiation Therapy.

This study will explore whether ivabradine lowers heart rate, and thus improves exercise capacity, in survivors of lymphoma who have an elevated resting heart rate as a side effect of prior radiati...

Diagnosis: Pediatric Non-Hodgkin Lymphoma, Pediatric Hodgkin Lymphoma, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma


Protocol Number: 17-022